Predictive Oncology Inc
NASDAQ:POAI

Watchlist Manager
Predictive Oncology Inc Logo
Predictive Oncology Inc
NASDAQ:POAI
Watchlist
Price: 5.48 USD 0.92% Market Closed
Market Cap: $18.6m

Relative Value

The Relative Value of one POAI stock under the Base Case scenario is hidden USD. Compared to the current market price of 5.48 USD, Predictive Oncology Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

POAI Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

POAI Competitors Multiples
Predictive Oncology Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Predictive Oncology Inc
NASDAQ:POAI
18.6m USD 25.5 -0.2 -1.8 -1.8
US
Medline Inc
NASDAQ:MDLN
60B USD 0 0 0 0
JP
Hoya Corp
TSE:7741
8.9T JPY 9.8 35.7 25.7 30.9
CH
Alcon AG
SIX:ALC
29.6B CHF 3.8 37.3 15.4 30
DK
Coloplast A/S
CSE:COLO B
109.6B DKK 3.9 27.5 14.3 17.1
US
Align Technology Inc
NASDAQ:ALGN
13.5B USD 3.4 35.5 16.1 20.5
UK
ConvaTec Group PLC
LSE:CTEC
4.6B GBP 2.7 29.2 13 21.1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
42.8B CNY 9.4 26 23.5 23.5
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD 1.2 -19.7 19.6 92.4
CH
Ypsomed Holding AG
SIX:YPSN
3.9B CHF 5 20.4 13.2 18
US
Merit Medical Systems Inc
NASDAQ:MMSI
4.8B USD 3.2 40.4 18.4 30.7
P/E Multiple
Earnings Growth PEG
US
Predictive Oncology Inc
NASDAQ:POAI
Average P/E: 31.5
Negative Multiple: -0.2
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
JP
Hoya Corp
TSE:7741
35.7
13%
2.7
CH
Alcon AG
SIX:ALC
37.3
25%
1.5
DK
Coloplast A/S
CSE:COLO B
27.5
22%
1.2
US
Align Technology Inc
NASDAQ:ALGN
35.5
27%
1.3
UK
ConvaTec Group PLC
LSE:CTEC
29.2
33%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
26
9%
2.9
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -19.7 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
20.4
32%
0.6
US
Merit Medical Systems Inc
NASDAQ:MMSI
40.4
30%
1.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Predictive Oncology Inc
NASDAQ:POAI
Average EV/EBITDA: 17.7
Negative Multiple: -1.8
N/A N/A
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
JP
Hoya Corp
TSE:7741
25.7
11%
2.3
CH
Alcon AG
SIX:ALC
15.4
8%
1.9
DK
Coloplast A/S
CSE:COLO B
14.3
8%
1.8
US
Align Technology Inc
NASDAQ:ALGN
16.1
13%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
13
10%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.5
15%
1.6
CA
Bausch + Lomb Corp
NYSE:BLCO
19.6
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
13.2
21%
0.6
US
Merit Medical Systems Inc
NASDAQ:MMSI
18.4
16%
1.2